G43 G44
Conditions
Interventions
Group 1: Physiotherapeutic examination of patients with head- or facial pain by a previous manual examination of the cervical spine and testing for sensitivity of neck and face before and after an inj
Sponsors
Universitätsklinikum Hamburg-Eppendorf
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Adult patients with high frequency episodic or chronic migraine, cluster headache or facial pain diagnosed by a neurologist experienced in headache based on the classification of IHS III that should receive a GON-block as a clinical required intervention.
Exclusion criteria
Exclusion criteria: diagnosed pathology of the cervical spine, trauma of the cervical spine in the past, pregnancy or lactation period, pain medication in more than 10 days a month to exclude medication overuse headache, relevant internistic, psychiatric or neurologic deseases, misuse of drugs or alcohol, allergy to local anaestesic or cortisone.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Headache frequency. Measured in pain days per 4 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Migraine days per 4 weeks. Severity and duration of headache. Duration of numbness after injection in hours. Frequency, kind and dosage of acute medication. Possible side effects of the GON-Block. All measured with headache diary. Level of disability due to headache measured with the Migraine Disability Index (MIDAS), due to facial pain measured with the Craniofacial Pain And Disability Inventory (CF_PDI), due to neck pain measured with the Neck Disability Index (NDI). Change in sensitivity to touch (von Frey Filaments) and pressure (manual palpation). Change in allodynia via the Allodynia Symptome Checklist (ASC-12) and the Global Rating of Change (GROC). | — |
Countries
Germany
Contacts
Public ContactAnnika Schwarz
UKE
Outcome results
None listed